MOTS-c Liquid Spray · Research brief
Why Is MOTS-c So Expensive? MOTS-c Cost Per Month
Short answer
Almost none of what you pay for a MOTS-c vial is the peptide itself. The amino acid building blocks for a 16-residue sequence are commodity chemistry. What costs real money is everything that happens after the final coupling step: purification that discards a meaningful share of the crude material, HPLC and mass spectrometry on every lot, lyophilization, cold-chain packaging, and…
Key takeaways
- MOTS-c is a 16-amino-acid mitochondrial-derived peptide, and each of its 16 coupling steps compounds yield loss, which is the root reason the compound is expensive to make.
- The sequence MRWQEMGYIFYPRKLR contains two oxidation-prone methionines, one tryptophan, and three slow-coupling arginines, all of which raise purification difficulty.
- HPLC purity and net peptide content are different measurements, and a vial can show 99% purity while containing less peptide mass than the label implies.
- Fixed per-vial costs such as lyophilization, stoppering, QC sampling and cold-chain packaging mean a 10mg format usually lowers the MOTS-c cost per month versus two 5mg vials.
- Batch-specific analytics cost the same whether a lot is 50 vials or 5,000, which is why small-batch synthesis carries a higher per-milligram price.
- Reconstituted peptide has a finite refrigerated window, so discarded solution raises real monthly spend more than sticker price does.
Almost none of what you pay for a MOTS-c vial is the peptide itself. The amino acid building blocks for a 16-residue sequence are commodity chemistry. What costs real money is everything that happens after the final coupling step: purification that discards a meaningful share of the crude material, HPLC and mass spectrometry on every lot, lyophilization, cold-chain packaging, and the vials that fail quality control and never reach a shelf.
We synthesize in small batches at Real Peptides, and our team sees the same pattern in every lot review. The cheaper a MOTS-c listing looks, the fewer of those steps someone actually paid for. Price, in this corner of the market, is mostly a proxy for documentation.
What is the MOTS-c cost per month, and why is MOTS-c so expensive?
Research-grade MOTS-c typically runs roughly the price of one 10mg vial for a month of bench work, with vial prices varying widely by supplier and by how much testing is documented. The MOTS-c cost per month is driven by synthesis difficulty and per-batch analytics, not by demand, because much of each batch never ships.
The common assumption is that peptide pricing tracks milligrams. It doesn't. You are buying verified identity and verified purity attached to a specific batch number, and those are fixed costs that get spread across however many vials survive QC. The most common search behind this page is a blunt one: mots c cost per month. This piece covers why a 16-amino-acid sequence is genuinely hard to make, what a certificate of analysis costs to produce, and how vial size quietly decides your real monthly spend.
Sixteen amino acids, and every coupling is a chance to fail
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid peptide encoded inside mitochondrial DNA rather than the nuclear genome, first described in a 2015 Cell Metabolism paper. Research suggests it signals through AMPK (AMP-activated protein kinase), the enzyme complex that shifts cellular metabolism toward substrate oxidation. That biology is why demand exists. The chemistry is why it costs what it does.
The sequence is MRWQEMGYIFYPRKLR. Count the problem residues: two methionines, one tryptophan, three arginines. Methionine and tryptophan both oxidize readily during the trifluoroacetic acid cleavage step, which is why scavenger cocktails and inert atmospheres get used. Arginine couples slowly and is a known source of deletion sequences.
Standard Fmoc solid-phase peptide synthesis builds the chain one residue at a time, so 16 residues means 16 coupling cycles. The arithmetic is unforgiving. At 99% efficiency per coupling, theoretical yield is about 85%. At 97%, it falls to roughly 61%. Everything lost shows up as truncated or deletion peptides that differ from the target by a single residue, and separating those on reversed-phase HPLC is the expensive part of the whole process.
Our team has reviewed enough crude chromatograms to say it plainly: the purification step, not the synthesis step, is where most of a MOTS-c batch and most of its cost disappear.
What a certificate of analysis actually costs to produce
A batch-specific certificate of analysis is not a formality. It's an analytical workload that gets paid for whether the batch is 50 vials or 5,000. Reversed-phase HPLC establishes purity as a percentage of total peak area, usually read at 214 or 220 nanometres. Electrospray or MALDI-TOF mass spectrometry confirms the observed mass matches the expected mass of roughly 2.2 kilodaltons for this sequence. Small batches mean those fixed testing costs are amortized across fewer units, which is the single most under-discussed reason small-batch peptides cost more per milligram.
Here's the detail most suppliers never explain, and it changes how you read a price. HPLC purity and peptide content are two different measurements. Purity tells you what fraction of the peptide-related material is your target sequence. Peptide content tells you how much of the powder in the vial is peptide at all, as opposed to residual trifluoroacetate counterions, water, and salts, which can account for a substantial share of dry mass. A vial labelled 10mg at 99% HPLC purity can still deliver noticeably less than 10mg of actual peptide if net peptide content was never determined by amino acid analysis or nitrogen determination.
That is why two vials with identical purity claims can differ in price by a wide margin, and why we publish documentation at our COA library rather than reprinting a generic chromatogram across every lot.
Vial size, batch economics, and how a monthly figure gets built
Cost per milligram falls as vial size rises, because a large share of what you pay is fixed per vial rather than per milligram. The lyophilization cycle, the borosilicate vial, the stopper and crimp seal, the label, the QC sample pulled from the lot, and the insulated shipper all cost roughly the same whether the vial holds 5mg or 10mg. That's the structural reason a 10mg format almost always beats two 5mg vials on the MOTS-c cost per month calculation.
Format matters too. A lyophilized powder such as MOTS-c 10mg is stable long-term at freezer temperature, while a pre-solubilized presentation like the MOTS-c liquid spray carries solvent, fill validation and different stability testing in its price.
The arithmetic that converts a vial price into a monthly line item is simple documentation math. If a lab record shows a 10mg vial reconstituted with 2 mL of solvent, the concentration is 5 mg/mL, and 0.1 mL of that solution contains 0.5mg. Multiply the milligrams a protocol consumes by the per-milligram price and you have your figure. Nothing here is a recommendation of quantity for any person or animal.
Storage failure inflates the real MOTS-c cost per month more than sticker price ever does. Lyophilized material held near minus 20 degrees Celsius stays stable for extended periods; once reconstituted, aqueous peptide belongs at 2 to 8 degrees Celsius and has a finite usable window. Discarded solution is money already spent. These compounds are supplied strictly for laboratory research, not for human or veterinary use, and anyone with a health question about an animal should talk to their veterinarian.
MOTS-c cost per month: what each price tier actually buys
The table below maps rough market tiers against the documentation each one typically carries, because the gap between tiers is almost entirely analytical, not chemical.
| Price tier (rough, per 10mg vial) | What the paperwork usually shows | Where it typically fails | Bottom line |
|---|---|---|---|
| Under roughly $40 | A purity percentage printed on the product listing, with no batch-linked certificate | No mass spectrometry identity confirmation, no peptide content figure, unknown lot age | Cheapest per milligram and the most likely to turn a failed experiment into a misread hypothesis |
| Roughly $40 to $80 | A certificate reused across multiple lots, usually an HPLC chromatogram alone | Chromatogram often not tied to the batch number on your vial; net peptide content unstated | Workable for pilot screening if you confirm the batch number matches, but budget for your own confirmatory testing |
| Roughly $80 to $150 | Batch-specific HPLC plus MS identity, third-party issued and archived | Smaller batch sizes and slower restocks between production runs | Highest sticker price, lowest hidden cost, because the verification you would otherwise repeat is already paid for |
What If: MOTS-c sourcing and budgeting scenarios
What if one supplier's MOTS-c is half the price of everyone else's?
Ask for the batch-specific certificate before ordering, and check that the lot number on the document matches the lot number on the vial. A price that sits far below the market usually reflects skipped mass spectrometry, skipped peptide content determination, or crude material that was never fully purified. Deletion sequences differing by a single residue are invisible to the eye and will still bind, misbehave, or do nothing at all in an assay.
What if the powder looks like loose dust instead of a solid cake?
Photograph it, record the lot number, and contact the supplier before adding solvent. A properly lyophilized peptide usually forms a coherent cake or a fine adherent film; loose, shifted powder can indicate a shipping temperature excursion or an interrupted freeze-drying cycle. Appearance alone does not prove degradation, and it does not disprove it either, which is exactly why archived batch analytics matter more than visual inspection.
What if the certificate of analysis has no batch number on it?
Treat it as marketing material rather than analytical data. A certificate without a lot identifier cannot be tied to the vial in your hand, so it documents nothing about what you received. Legitimate documentation carries the batch number, the test date, the analytical method, and the retention time or observed mass. Reused generic certificates are one of the clearest signals that a low MOTS c cost per month was achieved by cutting testing.
What if a reconstituted vial gets discarded before a study period ends?
Recalculate your effective spend using milligrams actually consumed rather than milligrams purchased. Wasted solution is the largest hidden driver of MOTS-c cost per month in most small labs, and it usually traces back to reconstituting a full 10mg vial for work that only required a fraction of it. Matching vial size to planned consumption, and logging reconstitution dates, fixes this faster than switching suppliers.
The uncomfortable part of research peptide pricing
Here's the honest answer: a large share of the price difference between cheap and expensive MOTS-c is testing you either pay for once, at the supplier, or pay for twice, at your own bench. Peptide synthesis is not proprietary wizardry. Fmoc chemistry is well established and widely available. What separates a $30 vial from a $110 vial is whether someone ran batch-specific mass spectrometry, determined peptide content, and archived the result under a lot number you can verify. If you buy the cheap vial and then send it out for confirmatory analysis, you have spent more and waited longer.
For context on the compound itself, our MOTS-c research overview collects what the literature reports, while the full peptide catalog shows how the same small-batch synthesis and documentation standard applies across every sequence we produce.
The MOTS-c cost per month on your invoice is really a measure of how much verification somebody already paid for. Peptide pricing feels opaque because the expensive parts are invisible: the discarded fraction of a purification run, the mass spec trace nobody reads, the failed lot that never shipped. Cheap vials aren't cheap peptide. They're the same peptide with the verification removed, and the cost of that omission lands months later, when an experiment produces a clean, confident, entirely meaningless result.
References
Peer-reviewed sources on MOTS-c indexed in PubMed, listed for research context. Real Peptides supplies MOTS-c for laboratory research use only.
- MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner. Free radical biology & medicine, 2026. PMID 41520850. doi:10.1016/j.freeradbiomed.2026.01.002
- Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction. Biomedicines, 2026. PMID 42193373. doi:10.3390/biomedicines14051048
- MOTS-c, a mitochondrial-derived peptide, ameliorates lysosomal membrane permeability and improves survival of soft tissue transplantation. Autophagy, 2026. PMID 42153537. doi:10.1080/15548627.2026.2677180
- Mitochondrial-derived peptide MOTS-c targets SLC7A11 to preserve spermatogenesis by suppressing ferroptosis. Free radical biology & medicine, 2026. PMID 41933740. doi:10.1016/j.freeradbiomed.2026.03.074
- MOTS-c attenuates cardiac dysfunction following high altitude exposure by promoting mitophagy. Free radical biology & medicine, 2026. PMID 41654147. doi:10.1016/j.freeradbiomed.2026.01.064
- Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes. Experimental & molecular medicine, 2025. PMID 40855115. doi:10.1038/s12276-025-01521-1
- MOTS-c attenuates mitochondrial dysfunction induces pyroptosis and cartilage degradation in osteoarthritis via an Nrf2-Dependent Mechanism. Free radical biology & medicine, 2025. PMID 41043625. doi:10.1016/j.freeradbiomed.2025.09.056
- MOTS-c Promotes Glycolysis via AMPK-HIF-1α-PFKFB3 Pathway to Ameliorate Cardiopulmonary Bypass-induced Lung Injury. American journal of respiratory cell and molecular biology, 2025. PMID 40035775. doi:10.1165/rcmb.2024-0533OC
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA